Alexei Gogolev
Stock Analyst at JP Morgan
(3.64)
# 796
Out of 5,141 analysts
96
Total ratings
53.52%
Success rate
6.7%
Average return
Main Sectors:
Stocks Rated by Alexei Gogolev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Overweight | $330 → $296 | $180.31 | +64.16% | 2 | Feb 20, 2026 | |
| PHR Phreesia | Maintains: Overweight | $29 → $24 | $12.71 | +88.83% | 2 | Feb 20, 2026 | |
| DOCS Doximity | Maintains: Neutral | $40 → $33 | $25.55 | +29.16% | 3 | Feb 20, 2026 | |
| INTA Intapp | Maintains: Overweight | $70 → $58 | $21.83 | +165.69% | 4 | Feb 4, 2026 | |
| PTC PTC Inc. | Downgrades: Underweight | $205 → $162 | $155.16 | +4.41% | 2 | Feb 2, 2026 | |
| APPF AppFolio | Maintains: Overweight | $330 → $300 | $172.23 | +74.19% | 5 | Jan 30, 2026 | |
| VRSN VeriSign | Maintains: Neutral | $270 → $271 | $215.91 | +25.52% | 2 | Jan 6, 2026 | |
| IOT Samsara | Maintains: Neutral | $46 → $48 | $26.79 | +79.17% | 5 | Dec 5, 2025 | |
| PEGA Pegasystems | Maintains: Overweight | $65 → $74 | $45.36 | +63.14% | 1 | Dec 5, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $126 → $129 | $78.90 | +63.51% | 1 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $26 | $23.30 | +11.59% | 6 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $56 → $51 | $33.84 | +50.71% | 3 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $200 | $90.64 | +120.65% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $189 → $166 | $66.90 | +148.13% | 5 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $86 → $94 | $71.38 | +31.69% | 3 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 → $101 | $49.87 | +102.53% | 6 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $271 → $288 | $127.66 | +125.60% | 9 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $85 | $52.34 | +62.40% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $45 | $17.03 | +164.24% | 4 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $10 → $11 | $10.32 | +6.59% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $526 | $317.01 | +65.93% | 3 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $36 → $32 | $4.77 | +570.86% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $28 | $9.03 | +210.08% | 2 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $247 → $249 | $138.85 | +79.33% | 4 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $73 → $55 | $56.24 | -2.20% | 4 | Mar 11, 2020 |
Veeva Systems
Feb 20, 2026
Maintains: Overweight
Price Target: $330 → $296
Current: $180.31
Upside: +64.16%
Phreesia
Feb 20, 2026
Maintains: Overweight
Price Target: $29 → $24
Current: $12.71
Upside: +88.83%
Doximity
Feb 20, 2026
Maintains: Neutral
Price Target: $40 → $33
Current: $25.55
Upside: +29.16%
Intapp
Feb 4, 2026
Maintains: Overweight
Price Target: $70 → $58
Current: $21.83
Upside: +165.69%
PTC Inc.
Feb 2, 2026
Downgrades: Underweight
Price Target: $205 → $162
Current: $155.16
Upside: +4.41%
AppFolio
Jan 30, 2026
Maintains: Overweight
Price Target: $330 → $300
Current: $172.23
Upside: +74.19%
VeriSign
Jan 6, 2026
Maintains: Neutral
Price Target: $270 → $271
Current: $215.91
Upside: +25.52%
Samsara
Dec 5, 2025
Maintains: Neutral
Price Target: $46 → $48
Current: $26.79
Upside: +79.17%
Pegasystems
Dec 5, 2025
Maintains: Overweight
Price Target: $65 → $74
Current: $45.36
Upside: +63.14%
HealthEquity
Dec 4, 2025
Maintains: Overweight
Price Target: $126 → $129
Current: $78.90
Upside: +63.51%
Nov 6, 2025
Maintains: Overweight
Price Target: $28 → $26
Current: $23.30
Upside: +11.59%
Nov 6, 2025
Maintains: Neutral
Price Target: $56 → $51
Current: $33.84
Upside: +50.71%
Oct 31, 2025
Maintains: Overweight
Price Target: $222 → $200
Current: $90.64
Upside: +120.65%
Aug 6, 2025
Maintains: Neutral
Price Target: $189 → $166
Current: $66.90
Upside: +148.13%
Jul 24, 2025
Maintains: Neutral
Price Target: $86 → $94
Current: $71.38
Upside: +31.69%
Jul 23, 2025
Maintains: Overweight
Price Target: $87 → $101
Current: $49.87
Upside: +102.53%
Jun 25, 2025
Maintains: Overweight
Price Target: $271 → $288
Current: $127.66
Upside: +125.60%
Apr 9, 2025
Maintains: Overweight
Price Target: $97 → $85
Current: $52.34
Upside: +62.40%
Dec 9, 2024
Maintains: Overweight
Price Target: $42 → $45
Current: $17.03
Upside: +164.24%
Aug 7, 2024
Maintains: Underweight
Price Target: $10 → $11
Current: $10.32
Upside: +6.59%
Feb 15, 2024
Maintains: Overweight
Price Target: $500 → $526
Current: $317.01
Upside: +65.93%
Aug 9, 2023
Maintains: Underweight
Price Target: $36 → $32
Current: $4.77
Upside: +570.86%
Jul 31, 2023
Maintains: Outperform
Price Target: $27 → $28
Current: $9.03
Upside: +210.08%
Mar 11, 2020
Maintains: Overweight
Price Target: $247 → $249
Current: $138.85
Upside: +79.33%
Mar 11, 2020
Upgrades: Neutral
Price Target: $73 → $55
Current: $56.24
Upside: -2.20%